Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Achillion Pharmaceut (ACHN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 433,787
  • Shares Outstanding, K 138,590
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,240 K
  • 36-Month Beta 1.28
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.13
  • Low Estimate -0.14
  • Prior Year -0.14
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.90 +0.34%
on 10/15/18
3.98 -26.88%
on 10/03/18
-0.28 (-8.78%)
since 09/14/18
3-Month
2.33 +24.89%
on 08/06/18
3.98 -26.88%
on 10/03/18
-0.23 (-7.32%)
since 07/13/18
52-Week
2.33 +24.89%
on 08/06/18
4.63 -37.15%
on 10/16/17
-1.68 (-36.60%)
since 10/13/17

Most Recent Stories

More News
Achillion to Present at the Leerink Partners Roundtable Series

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) announced today that Joseph Truitt, President and Chief Executive Officer of Achillion, will present at the Leerink Partners Roundtable Series: Rare Disease...

ACHN : 2.91 (-7.03%)
The Zacks Analyst Blog Highlights: Illumina, Celgene , Athersys and Achillion

The Zacks Analyst Blog Highlights: Illumina, Celgene , Athersys and Achillion

CELG : 81.83 (-0.91%)
ILMN : 313.41 (-2.57%)
ACHN : 2.91 (-7.03%)
ATHX : 2.08 (+4.52%)
IPOs and Foreign Investment Propel Biotech: 4 Top Picks

A steady influx of foreign as well as domestic investments in U.S. biotech has gone a long way in boosting gains for the space.

CELG : 81.83 (-0.91%)
TBIO : 7.15 (-4.16%)
ACHN : 2.91 (-7.03%)
ILMN : 313.41 (-2.57%)
NTGN : 8.42 (-7.06%)
ATHX : 2.08 (+4.52%)
Achillion Appoints Paul Firuta Chief Operating Officer

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced the appointment of Paul Firuta to the position of Executive Vice President and Chief Operating Officer effective immediately. Mr. Firuta,...

QURE : 27.58 (-3.33%)
ACHN : 2.91 (-7.03%)
Why Is Achillion (ACHN) Up 24.7% Since Last Earnings Report?

Achillion (ACHN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ACHN : 2.91 (-7.03%)
Achillion to Present at the Baird 2018 Global Healthcare Conference

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) announced today that Joseph Truitt, President and Chief Executive Officer of Achillion, will present at the Baird 2018 Global Healthcare Conference on Thursday,...

ACHN : 2.91 (-7.03%)
Achillion Appoints Dr. Steven Zelenkofske as Chief Medical Officer and Further Strengthens Clinical Development Team

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced the appointment of Steven Zelenkofske, D.O. to the position of Executive Vice President and Chief Medical Officer, effective immediately....

ACHN : 2.91 (-7.03%)
Recent Analysis Shows Ferroglobe, AXT, ChemoCentryx, RedHill Biopharma, GTx, and Achillion Pharmaceuticals Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ferroglobe PLC (NASDAQ:GSM),...

GSM : 6.87 (+3.62%)
RDHL : 8.32 (+4.13%)
AXTI : 6.35 (+0.95%)
ACHN : 2.91 (-7.03%)
CCXI : 10.55 (+3.03%)
GTXI : 1.61 (-6.40%)
Achillion Expands Management Team With Appointment of Anthony S. Gibney as Chief Business Officer

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced the appointment of Anthony S. Gibney to the position of Executive Vice President and Chief Business Officer, effective immediately. Mr. Gibney...

ACHN : 2.91 (-7.03%)
Achillion: 2Q Earnings Snapshot

NEW HAVEN, Conn. (AP) _ Achillion Pharmaceuticals Inc. (ACHN) on Wednesday reported a loss of $17.2 million in its second quarter.

ACHN : 2.91 (-7.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ACHN with:

Business Summary

ACHILLION PHARMACEUTICALS, INC. is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. The company's proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused...

See More

Key Turning Points

2nd Resistance Point 3.25
1st Resistance Point 3.08
Last Price 2.91
1st Support Level 2.82
2nd Support Level 2.73

See More

52-Week High 4.63
Fibonacci 61.8% 3.75
Fibonacci 50% 3.48
Fibonacci 38.2% 3.21
Last Price 2.91
52-Week Low 2.33

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar